All Articles

Revenue missed and its stock plunged, but Quanterix is betting on a new C-suite and its Alzheimer's test to navigate market headwinds and deliver on its promise.

Hyosung’s impressive H1 2026 results reveal a shrewd strategy: localizing US power grid production for the AI boom while betting on bio-textiles and humanists.

A new platform is bundling JAŸ-Z VIP tickets with luxury hotels in real-time. Is this AI-powered concierge the end of ticket scalping and travel headaches?

The biotech pioneering cellular rejuvenation just added the finance chief behind Spark's $4.3B sale to its board. It’s a clear sign the firm is preparing to scale.

The new IBQT fund offers a pre-packaged equity and bitcoin portfolio, signaling a major step in mainstreaming digital assets for Canadian investors.

Kent County is betting on AI to clean up its waste stream. But as robots sift through garbage, are they solving a crisis or just making a flawed system run better?

Heron Therapeutics withdraws guidance after a patent blow to its top drug, forcing a strategic review. Can strong growth in new acute care products save it?

UNICO Hotel Collection expands beyond Mexico, betting its unique "local immersion" model can disrupt Jamaica's competitive all-inclusive luxury landscape.

Private equity firm AE Industrial launches Attilius Technologies, a secretive intelligence platform born from acquisition, aiming to dominate the national security market.

USSOCOM's new SOF RACER consortium, powered by BMNT, scraps fees and lengthy proposals to lure commercial tech. Is this the future of defense acquisition?

Axi is the first online broker to partner with a pro golf tour. The Nguyen Report deconstructs the strategy, the risks, and why this deal is a playbook for the future.

As children return to school, many Arizona adults are starting their own educational journeys, pivoting to high-demand trades in months, not years.

Members Trust Company's appointment of Anna Weyl is more than a new hire; it's a strategic play for the complex world of ultra-high-net-worth clients.

As immigration enforcement empties classrooms, EdTrust's strategic acquisition of the National Newcomer Network signals a major new front in the battle for equity.

As the ashwagandha market booms, quality concerns rise. OmniActive's Zenroot secures USP verification, offering a trusted, low-dose solution for brands.

Terra Clean Energy is using 3D modeling to resurrect a historic Utah mine, betting that digital analysis of old data can fuel America's new energy future.

A pilot in Tianjin merges IoT sensors with insurance to tackle failing elevators, promising a 20% cost cut. Is this the blueprint for smart urban infrastructure?

Amid its pending sale to Zymeworks, Theravance Biopharma’s Q2 results reveal a lesson in resilience, with strong YUPELRI sales and deep cost cuts.

The new ARIA ETF, led by an AI Ph.D., uses proprietary machine learning not to replace judgment, but to sharpen it across U.S. and Asian markets.

A new drug, divesiran, shows stunning success in trials, offering hope to those with a rare blood cancer by potentially replacing frequent phlebotomies with a quarterly shot.